| Product Code: ETC9615446 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan CNV (Choroidal NeoVascularization) Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan CNV (Choroidal NeoVascularization) Market - Industry Life Cycle |
3.4 Taiwan CNV (Choroidal NeoVascularization) Market - Porter's Five Forces |
3.5 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Taiwan CNV (Choroidal NeoVascularization) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of age-related macular degeneration (AMD) in Taiwan |
4.2.2 Technological advancements in diagnostic tools and treatment options for CNV |
4.2.3 Growing awareness and early detection programs for CNV |
4.3 Market Restraints |
4.3.1 High treatment costs associated with CNV therapies |
4.3.2 Limited reimbursement policies for CNV treatments in Taiwan |
5 Taiwan CNV (Choroidal NeoVascularization) Market Trends |
6 Taiwan CNV (Choroidal NeoVascularization) Market, By Types |
6.1 Taiwan CNV (Choroidal NeoVascularization) Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Fluorescein AngiographyOptical Coherence Tomography, 2021- 2031F |
6.1.4 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Taiwan CNV (Choroidal NeoVascularization) Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Anti-VEGF, 2021- 2031F |
6.2.3 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Photodynamic Therapy, 2021- 2031F |
6.2.4 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Thermal Laser, 2021- 2031F |
6.2.5 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Taiwan CNV (Choroidal NeoVascularization) Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.4 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.5 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Taiwan CNV (Choroidal NeoVascularization) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By online Pharmacies, 2021- 2031F |
6.4.5 Taiwan CNV (Choroidal NeoVascularization) Market Revenues & Volume, By Others, 2021- 2031F |
7 Taiwan CNV (Choroidal NeoVascularization) Market Import-Export Trade Statistics |
7.1 Taiwan CNV (Choroidal NeoVascularization) Market Export to Major Countries |
7.2 Taiwan CNV (Choroidal NeoVascularization) Market Imports from Major Countries |
8 Taiwan CNV (Choroidal NeoVascularization) Market Key Performance Indicators |
8.1 Number of patients diagnosed with CNV annually |
8.2 Adoption rate of new CNV treatment technologies in Taiwan |
8.3 Success rate of CNV treatment interventions |
8.4 Number of healthcare facilities offering CNV treatment services |
8.5 Level of government funding allocated to CNV research and treatment advancements |
9 Taiwan CNV (Choroidal NeoVascularization) Market - Opportunity Assessment |
9.1 Taiwan CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Taiwan CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 Taiwan CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 Taiwan CNV (Choroidal NeoVascularization) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Taiwan CNV (Choroidal NeoVascularization) Market - Competitive Landscape |
10.1 Taiwan CNV (Choroidal NeoVascularization) Market Revenue Share, By Companies, 2024 |
10.2 Taiwan CNV (Choroidal NeoVascularization) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here